Tech Company Financing Transactions

TRexBio Funding Round

Delos Capital, Agent Capital and Alexandria Venture Investments participated in a $84 million Series B funding round for TRexBio. The round was announced by the company on 11/14/2024.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

681 Gateway Blvd.
San Francisco, CA 94080
USA

Phone

Undisclosed

Website

www.trex.bio

Email Address

Not Recorded

Overview

TRexBio is a discovery stage biotechnology company leveraging cutting edge computational biology tools, a focus on human tissue, and expertise in immunobiology to develop revolutionary therapeutics for cancer and inflammatory diseases.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Johnston Erwin

        

Chief Medical Officer

Ovid Trifan

        

Chief Scientific Officer

Melanie Kleinschek

        

VP - Bus. Development

Laura Berner

        

Browse more venture capital transactions:

Prev: 11/14/2024: Tangible venture capital transaction
Next: 11/14/2024: Pemo venture capital transaction

Share this article

News on VC Transactions

We do our best to report on all VC transactions involving tech companies. VC transactions reported here are sourced from a variety of public sources. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary